OncologyInformationService
Real World Databases
Evidence based Healthcare and Market Research

O.I.s) International: TherapyMonitor Multiple Myeloma

Dear participant,

Thank you for taking part in our project, TherapyMonitor Multiple Myeloma International!
From this website, you can access our online documentation portal via the link below.

Inclusion criteria:

Please record patients with Multiple Myeloma (ICD-10 90.0) who

  • received two prior therapy lines and,
  • who started a third line of treatment between 01/01/2019 to 30/06/2021.

Exclusion criteria:

  • The patient may not have been a participant in a clinical study (independent of line of treatment)
  • The patient may not have a concomitant or prior diagnosis of a malignancy besides multiple myeloma, unless the patient is considered to have been medically stable for a minimum period of 2 years (no active therapy except hormonal therapy for concomitant malignancies). Patients with curative treatment for non-melanoma skin cancer are exempt from this exclusion criterion and are cleared for documentation.

 

Please complete your documentation by 01/05/2022 at the latest.

 

To Login to the documentation database:

  • Click on the link below and
  • Enter your user ID and password.

To Online Documentation: TM Multiple Myeloma

 

If you have any questions about the project, you can contact us
per E-Mail: tm_uk[at]oncologyinformationservice.com

Many thanks for your participation!

Evgeniia Kharitonova

Project Lead